Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Telapristone (Primary) ; Telapristone (Primary)
- Indications Early breast cancer
- Focus Pharmacokinetics
- 28 Jun 2017 Planned End Date changed from 1 Oct 2017 to 1 Mar 2021.
- 10 Jun 2017 Biomarkers information updated
- 26 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.